Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Accenture’s 300-page SEC disclosures can bury the datapoints that move the stock—cloud revenue mix, new bookings, and how many consultants billable hours really grew. Finding those nuggets across a dense 10-K, multiple 10-Q updates, and rapid-fire 8-K acquisitions is the challenge every ACN investor faces.
Stock Titan solves that problem by marrying real-time EDGAR feeds with AI-powered summaries that translate complex language into clear takeaways. Need the next Accenture quarterly earnings report 10-Q filing? It lands here seconds after the SEC posts it, alongside a plain-English breakdown of segment margins and headcount trends. Curious about Accenture insider trading Form 4 transactions? Our dashboard flags executive buys and sells the moment they’re filed, complete with historical context.
Explore every disclosure type in one place:
- Annual report 10-K—see how consulting versus managed-services revenue shifts, with Accenture annual report 10-K simplified by AI.
- Quarterly 10-Q—track bookings momentum and free-cash-flow swings.
- 8-K material events—instant reads on acquisitions, leadership changes, or dividend announcements: Accenture 8-K material events explained.
- Proxy statement—understand Accenture proxy statement executive compensation without sifting through tables.
- Form 4—monitor Accenture executive stock transactions Form 4 in real time.
Whether you’re modeling cash flow, comparing segment profitability, or watching Accenture Form 4 insider transactions real-time, Stock Titan delivers the data and plain-language insight you need—no PDF spelunking required.
UBS AG has filed a Rule 424(b)(2) pricing supplement for a small, $1.504 million issuance of Trigger Autocallable Contingent Yield Notes with Memory Interest maturing 14 July 2028. The notes are unsecured, unsubordinated obligations of UBS AG London Branch and are linked to the weaker performer of the Russell 2000® Index (RTY) and the S&P 500® Index (SPX).
Coupon mechanics. Investors receive a 7.35% p.a. fixed contingent coupon (paid semi-annually, $36.75 per $1,000) only when both indices close at or above their 70% coupon barriers on an observation date. Missed coupons are not lost: the memory-interest feature pays all previously unpaid coupons the next time both indices meet the barrier.
Autocall. On any observation date before final valuation, the notes are automatically called if both indices are at or above 100% of their initial levels. Investors then receive the $1,000 principal plus the current and any accrued coupons; no further payments occur.
Principal risk. If the notes are not called and, at maturity, either index closes below its 70% downside threshold, repayment is $1,000 × (1 + return of the worst index). A 40% index loss therefore translates into a 40% capital loss. Full principal is protected only if both indices stay above their thresholds.
Key terms.
- Initial levels: RTY 2,234.827; SPX 6,259.75
- Coupon/Downside barriers: 70% of initial levels (RTY 1,564.379; SPX 4,381.83)
- Observation dates: semi-annual; settlement T+3
- Estimated initial value: $962.20 (96.22% of issue price) reflects embedded fees and UBS funding spread
- Fees: $15 underwriting discount plus $6 structuring fee per note; net proceeds $985 per $1,000
Risk highlights. Investors face (i) full market risk below the 70% thresholds, (ii) contingent and potentially zero income, (iii) UBS credit risk, (iv) liquidity constraints—no exchange listing and discretionary market-making by UBS Securities LLC—and (v) valuation friction because the issue price exceeds the model-based estimated value by 3.78%.
Investor profile. The product targets investors comfortable with equity downside risk, seeking enhanced coupon income, willing to forgo upside participation and able to hold to maturity or autocall.
Enovix Corp (ENVX) � Form 4 insider filing
Chief Accounting Officer Kristina Truong reported a Code F transaction on 07/13/2025, indicating that 1,013 common shares were withheld to cover taxes upon the vesting of restricted stock units (RSUs). The shares were valued at $14.07 each, an implied tax-withholding value of roughly $14,200. Following the withholding, the insider’s direct beneficial ownership stands at 207,112 common shares, which includes 173,617 un-settled RSUs.
No open-market purchases or sales occurred, and no new derivative positions were created or exercised. The filing is largely administrative, reflecting routine equity compensation settlement rather than a discretionary trade.
Enovix Corp (ENVX) � Form 4 insider filing
Chief Accounting Officer Kristina Truong reported a Code F transaction on 07/13/2025, indicating that 1,013 common shares were withheld to cover taxes upon the vesting of restricted stock units (RSUs). The shares were valued at $14.07 each, an implied tax-withholding value of roughly $14,200. Following the withholding, the insider’s direct beneficial ownership stands at 207,112 common shares, which includes 173,617 un-settled RSUs.
No open-market purchases or sales occurred, and no new derivative positions were created or exercised. The filing is largely administrative, reflecting routine equity compensation settlement rather than a discretionary trade.
Transaction overview: UBS AG is issuing $777,000 of unsubordinated, unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of The Kraft Heinz Company (KHC). The notes price on 11 Jul 2025, settle on 15 Jul 2025 and mature on 17 Jul 2028, unless called earlier.
- Face amount: $10 per note (minimum purchase 100 notes).
- Contingent coupon: 8.68% p.a. (paid quarterly � $0.217 per note) only when KHC closes � coupon barrier on an observation date.
- Coupon barrier / downside threshold: $19.00 (70% of initial level $27.14).
- Automatic call: Beginning 6 months after settlement and quarterly thereafter, if KHC closes � initial level ($27.14). Investors receive par + any due coupon; no further payments.
- Principal at maturity: � Par if KHC � downside threshold and notes were not called. � Par × (1 + underlying return) if KHC < threshold, resulting in 1-for-1 downside exposure to �100%.
- Estimated initial value: $9.62 (UBS internal model), 3.8% below issue price due to fees/hedging costs.
- Secondary market: No listing; UBS affiliates may make markets but are not obliged to do so.
Key risks highlighted by issuer:
- Loss of up to full principal if KHC falls >30% and notes are not called.
- Coupons contingent; investors may receive few or none.
- Credit risk of UBS AG senior debt.
- Potential illiquidity and bid–ask premium in secondary trading.
- Estimated value below issue price; early resale likely below $10.
Illustrative performance scenarios: UBS shows (1) early call after two quarters producing a 4.34% total return; (2) hold to maturity with KHC � threshold producing same 4.34% total return; (3) KHC down 33.5% at maturity producing a 31.3% loss.
Use-of-proceeds & distribution: UBS Securities LLC will purchase the notes less a $0.20 per-note underwriting discount and resell to UBS Financial Services Inc.; the offering raises net proceeds of � $761,460 for UBS. Because both dealers are UBS affiliates, the deal is a FINRA 5121 conflict-of-interest offering.
Investor suitability: Product targets investors comfortable with (i) single-name equity risk, (ii) contingent income, (iii) potential illiquidity, and (iv) UBS credit exposure. Not appropriate for investors seeking principal protection, guaranteed income, or equity upside participation.
Accenture plc (ACN) � Form 144 filing: The notice discloses that Julie Sweet intends to sell 2,251 Class A ordinary shares through UBS Financial Services on or about 11 July 2025. The aggregate market value of the planned sale is $646,509.71. During the last three months, Sweet sold 13,574 shares in three separate transactions, generating $4.997 million in gross proceeds. The proposed sale represents less than 0.001% of Accenture’s 680.3 million shares outstanding. The shares being sold were acquired via stock-award grants on 5 December 2023 (2,136 shares) and 5 January 2024 (115 shares). No other financial metrics or company-wide developments are provided in this filing.
Accenture plc (ACN) � Form 144 filing: The notice discloses that Julie Sweet intends to sell 2,251 Class A ordinary shares through UBS Financial Services on or about 11 July 2025. The aggregate market value of the planned sale is $646,509.71. During the last three months, Sweet sold 13,574 shares in three separate transactions, generating $4.997 million in gross proceeds. The proposed sale represents less than 0.001% of Accenture’s 680.3 million shares outstanding. The shares being sold were acquired via stock-award grants on 5 December 2023 (2,136 shares) and 5 January 2024 (115 shares). No other financial metrics or company-wide developments are provided in this filing.
Accenture plc (ACN) � Form 4 insider transaction
General Counsel and Corporate Secretary Joel Unruch reported the purchase of 90 Class A ordinary shares on 05 July 2025 at an average price of $303.795 per share. The acquisition was made through the company’s Voluntary Equity Investment Program, a payroll-deduction plan that allows executives to buy stock directly from Accenture. Following the transaction, Unruch’s direct holdings increased to 17,541 shares.
No derivative securities were involved and no dispositions were reported. The filing reflects an incremental ownership increase of roughly 0.5% to Unruch’s personal stake and is immaterial relative to Accenture’s total shares outstanding. Because the shares were purchased under a pre-arranged company program rather than on the open market, the signal is less indicative of discretionary conviction, but it nevertheless aligns executive interests with shareholders.
Tempus AI, Inc. (symbol TEM) filed a Form 144 indicating that insider Ryan Fukushima intends to sell 20,000 common shares through Morgan Stanley Smith Barney on or about 07/07/2025. At the reference price used in the filing, the shares have an aggregate market value of $1.22 million. The proposed sale represents roughly 0.012 % of the company’s 168.1 million shares outstanding.
The stock was originally acquired as restricted-stock awards on 10/14/2015. The form also discloses that, within the past three months, the same insider (including 10b5-1 plan sales) has already disposed of 47,820 shares, generating gross proceeds of approximately $2.79 million across three transactions (20 k on 06/03/2025, 7.82 k on 05/20/2025, and 20 k on 05/06/2025).
The filing does not disclose any material non-public information and states the seller’s representation of compliance with Rule 10b5-1. While the dollar value is meaningful, the percentage of ownership being liquidated is small, suggesting limited direct impact on the share float. Nevertheless, continued insider selling can influence investor sentiment.
Tempus AI, Inc. (symbol TEM) filed a Form 144 indicating that insider Ryan Fukushima intends to sell 20,000 common shares through Morgan Stanley Smith Barney on or about 07/07/2025. At the reference price used in the filing, the shares have an aggregate market value of $1.22 million. The proposed sale represents roughly 0.012 % of the company’s 168.1 million shares outstanding.
The stock was originally acquired as restricted-stock awards on 10/14/2015. The form also discloses that, within the past three months, the same insider (including 10b5-1 plan sales) has already disposed of 47,820 shares, generating gross proceeds of approximately $2.79 million across three transactions (20 k on 06/03/2025, 7.82 k on 05/20/2025, and 20 k on 05/06/2025).
The filing does not disclose any material non-public information and states the seller’s representation of compliance with Rule 10b5-1. While the dollar value is meaningful, the percentage of ownership being liquidated is small, suggesting limited direct impact on the share float. Nevertheless, continued insider selling can influence investor sentiment.